Through the review of the published studies, we discovered the role of ARID1A alterations or expression loss in the regulation of Bcl-2 expression and apoptosis of tumor cells which might participate into the resistance to EGFR-TKIs. The gene discussed is EGFR; the disease is neoplasm.